Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of different albuterol regimens on QT interval in children with moderate to severe asthma
IRCT20181006041252N5Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of salbutamol and ipratropium bromide in asthma (3 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoint: Change in QT interval. Started Nov 2018; status: completed.
02
Drugs
salbutamolipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20181006041252N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181006041252N5.